Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICH ADAPT: Acute BP Reduction in Intracerebral Hemorrhage
NCT00963976Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Jan 2007
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of labetalol, hydralazine, enalapril in intracerebral hemorrhage (ICH), sponsored by University of Alberta. Started Jan 2007; status: completed.
02
Drugs
labetalolhydralazineenalapril
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT00963976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00963976.